• Clinical Trials

     An important trial for which Griffith’s Clinical Trial Unit, alongside other research sites in Canada, USA, Europe, Turkey and Australia, is to evaluate the safety, tolerability and immunogenicity of a combined Meningococcal vaccine in young adults. Dr. Claire Williams, the Clinical Trial Unit’s Business and Operations Manager,  said, “We’re really pleased to be taking part […]

    Continue reading
  • Expand Schedule

    A two year old boy diagnosed with meningococcal sepsis in central Queensland has died. Local health officials have said, “Close contacts of the child, are being treated with antibiotics. As a precaution, we’re urging people in Mackay to be aware of symptoms of the disease.” Meningitis Centre Australia, (an advocacy group) chief executive Lisa D’Cruz […]

    Continue reading
  • Legal Woes

    Lance and Jennifer Gravatt have endured legal woes including investigations, inquests, claims and counter-claims since their son, Zac, a medical student died in 2009. After Zac died from a C strain of meningococcal septicemia, a coroner found a medical assessment for Zac was delayed because the health system was overwhelmed from swine flu and seasonal […]

    Continue reading
  • Maximum Protection

    Vaccines provide a longer protection from meningococcal disease. Several vaccine programs are being offered so please take advantage of them. Meningococcal ACWY Program – The meningococcal ACWY vaccine (Nimenrix ®) is provided under the National Immunisation Program and is administered at 12-months of age, through Schools IP for year 10 & adolescents 15-19 years old […]

    Continue reading
  • Know the Facts

    Quadrivalent meningococcal vaccine became available in the United States in 2005 which offers protection against ACWY strains of meningococcal meningitis or septicemia. In 2014-15, meningococcal serogroup B (MenB) vaccines became available. Young people 16-23 years of age who are determined to be at risk for this illness should be offered this new product. A recent […]

    Continue reading
  • Second Case

    A second student at Rutgers University in New Brunswick was hospitalized & diagnosed with bacterial meningitis. The first student had serogroup B meningococcal disease (MenB) & has been released from the hospital. Testing is being done to determine the specific type/serogroup of meningococcal bacteria in the 2nd student. School officials and doctors are trying to […]

    Continue reading
  • Student Alert

    Researchers led by Dr. Sarah Mbaeyi from the CDC’s National Center for Immunization and Respiratory Diseases, said “the finding highlights the urgent need to ensure that all students get vaccinated against the disease before they head off to a university”. The findings were published in the January issue of the journal Pediatrics. They found that […]

    Continue reading
  • Be Proactive

    Young adults are at higher risk for meningococcal meningitis, which can turn fatal quickly.

    Continue reading
  • Protection First

    Montgomery County, Maryland is requiring students entering seventh grade to get MCV4 (meningococcal meningitis) & other vaccines.

    Continue reading
  • Expand Coverage

    Western Australia Chemists’ proposal to give Meningococcal ACWY vaccine was backed by Meningitis Centre Australia Chairman Bruce Langoulant. Launching a social media campaign, to encourage 18 to 19-year-olds to get the vaccine & to help increase vaccination rate.

    Continue reading